Usa covid-19 vaccine symptoms patient Usa

NantKwest and ImmunityBio work on Covid-19 vaccines and drugs

Reading now: 215
www.pharmaceutical-technology.com

NantKwest and its sister firm ImmunityBio have partnered for the development of potential vaccines and therapeutics against Covid-19.

Currently, the companies are in discussions with the US Food and Drug Administration (FDA). The partnership combines NantKwest’s off-the-shelf, cell-based therapeutics expertise with ImmunityBio’s vaccine development and natural killer cell activation capabilities.

NantKwest and ImmunityBio will leverage their respective resources for the design and development of both vaccines and drugs.

NantKwest and ImmunityBio chairman and CEO Patrick Soon-Shiong said: “We’re in a race against time, but I am confident that, as a result of the incredible hard work the NantKwest, ImmunityBio, and the global scientific

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA